• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Excretion and metabolism of [14C]-pyridostigmine in the rat.

作者信息

Birtley R D, Roberts J B, Thomas B H, Wilson A

出版信息

Br J Pharmacol Chemother. 1966 Feb;26(2):393-402. doi: 10.1111/j.1476-5381.1966.tb01919.x.

DOI:10.1111/j.1476-5381.1966.tb01919.x
PMID:5912686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1510644/
Abstract
摘要

相似文献

1
Excretion and metabolism of [14C]-pyridostigmine in the rat.[14C] - 吡啶斯的明在大鼠体内的排泄与代谢
Br J Pharmacol Chemother. 1966 Feb;26(2):393-402. doi: 10.1111/j.1476-5381.1966.tb01919.x.
2
The excretion and metabolism of oral 14C-pyridostigmine in the rat.大鼠口服14C-吡啶斯的明的排泄与代谢
Br J Pharmacol. 1968 Oct;34(2):445-50. doi: 10.1111/j.1476-5381.1968.tb07064.x.
3
Metabolism of 14C-labeled pyridostigmine in myasthenia gravis. Evidence for multiple metabolites.14C标记的吡啶斯的明在重症肌无力中的代谢。多种代谢产物的证据。
Neurology. 1970 Jul;20(7):634-41. doi: 10.1212/wnl.20.7.634.
4
The effect of chronic pyridostigmine administration on pyridostigmine-14C metabolism in myasthenia gravis.慢性给予吡啶斯的明对重症肌无力患者体内吡啶斯的明-14C代谢的影响。
Neurology. 1971 May;21(5):550-2. doi: 10.1212/wnl.21.5.550.
5
Pyridostigmine metabolism in man.吡啶斯的明在人体内的代谢。
Clin Pharmacol Ther. 1972 May-Jun;13(3):393-9. doi: 10.1002/cpt1972133393.
6
In vitro synthesis of metabolites of 14C-pyridostigmine.14C-吡啶斯的明代谢物的体外合成
Experientia. 1974 May 15;30(5):527. doi: 10.1007/BF01926331.
7
Renal clearance of pyridostigmine in patients with myasthenia gravis.重症肌无力患者中吡啶斯的明的肾脏清除率。
Eur Neurol. 1977;16(1-6):69-72. doi: 10.1159/000114882.
8
Method for isolation and determination of pyridostigmine and metabolites in urine and blood.
J Chromatogr. 1982 Mar 12;228:235-44. doi: 10.1016/s0378-4347(00)80436-3.
9
Plasma clearance of neostigmine and pyridostigmine in rats with ligated renal pedicles.肾蒂结扎大鼠体内新斯的明和吡啶斯的明的血浆清除率
Eur J Pharmacol. 1973 Nov;24(2):252-5. doi: 10.1016/0014-2999(73)90079-4.
10
In vitro metabolism of neostigmine and pyridostigmine.新斯的明和吡啶斯的明的体外代谢
J Pharm Pharmacol. 1973 May;25(5):428-9. doi: 10.1111/j.2042-7158.1973.tb10045.x.

引用本文的文献

1
Orthogonal projection to latent structures and first derivative for manipulation of PLSR and SVR chemometric models' prediction: A case study.正交投影到潜在结构和一阶导数用于操纵 PLSR 和 SVR 化学计量模型的预测：案例研究。
PLoS One. 2019 Sep 25;14(9):e0222197. doi: 10.1371/journal.pone.0222197. eCollection 2019.
2
The biliary excretion of neostigmine in the rat.新斯的明在大鼠体内的胆汁排泄。
Br J Pharmacol Chemother. 1966 Dec;28(3):348-59. doi: 10.1111/j.1476-5381.1966.tb01903.x.
3
Pharmacodynamic analysis of contractile potentiation by cholinesterase inhibitors in rats.大鼠体内胆碱酯酶抑制剂对收缩增强作用的药效学分析
J Pharmacokinet Biopharm. 1996 Aug;24(4):327-48. doi: 10.1007/BF02353516.
4
The excretion and metabolism of oral 14C-pyridostigmine in the rat.大鼠口服14C-吡啶斯的明的排泄与代谢
Br J Pharmacol. 1968 Oct;34(2):445-50. doi: 10.1111/j.1476-5381.1968.tb07064.x.
5
In vitro synthesis of metabolites of 14C-pyridostigmine.14C-吡啶斯的明代谢物的体外合成
Experientia. 1974 May 15;30(5):527. doi: 10.1007/BF01926331.
6
Ligated renal pedicles and duration of action of neostigmine and pyridostigmine.结扎肾蒂以及新斯的明和吡啶斯的明的作用持续时间。
Br J Pharmacol. 1977 Aug;60(4):555-8. doi: 10.1111/j.1476-5381.1977.tb07534.x.
7
The pharmacokinetics of pyridostigmine and 3-hydroxy-N-methylpyridinium in the rat: dose-dependent effects after portal vein administration.吡啶斯的明和3-羟基-N-甲基吡啶鎓在大鼠体内的药代动力学：门静脉给药后的剂量依赖性效应
Br J Pharmacol. 1975 Nov;55(3):335-41. doi: 10.1111/j.1476-5381.1975.tb06936.x.

本文引用的文献

1
Determination of neostigmine and pyridostigmine in the urine of patients with myasthenia gravis.重症肌无力患者尿液中新斯的明和吡啶斯的明的测定。
Br J Pharmacol Chemother. 1962 Jun;18(3):617-24. doi: 10.1111/j.1476-5381.1962.tb01181.x.
2
METABOLIC RELEASE OF METHYL GROUPS FROM A SERIES OF N-METHYLPYRIDINIUM COMPOUNDS.一系列N-甲基吡啶鎓化合物甲基基团的代谢释放
Nature. 1964 May 16;202:699-700. doi: 10.1038/202699a0.
3
EXCRETION OF NEOSTIGMINE LABELLED WITH CARBON-14 IN URINE.尿中碳 - 14标记的新斯的明排泄情况
Nature. 1963 Dec 28;200:1330. doi: 10.1038/2001330a0.
4
THE COLLECTION OF EXPIRED VOLATILE SUBSTANCES.过期挥发性物质的收集
Br J Ind Med. 1963 Jul;20(3):248-9. doi: 10.1136/oem.20.3.248.
5
The toxicity of epichlorhydrin vapour.环氧氯丙烷蒸气的毒性。
Br J Ind Med. 1959 Jan;16(1):11-4. doi: 10.1136/oem.16.1.11.
6
Inhibition of the renal tubular excretion of tetraethylammonium and N'-methylnicotinamide by basic cyanine dyes.碱性花青染料对四乙铵和N'-甲基烟酰胺肾小管排泄的抑制作用。
J Pharmacol Exp Ther. 1956 Oct;118(2):204-19.
7
Metabolism of [14C]-neostigmine in the rat.[14C] -新斯的明在大鼠体内的代谢
Br J Pharmacol Chemother. 1965 Dec;25(3):763-70. doi: 10.1111/j.1476-5381.1965.tb01799.x.